Pediatric Endocrinology, Diabetes and Metabolism最新文献

{"title":"Systemic consequences of coeliac disease in children with type 1 diabetes - is it worth following a gluten-free diet?","authors":"Karolina Ruszkiewicz, Joanna Nazim","doi":"10.5114/pedm.2024.146861","DOIUrl":"10.5114/pedm.2024.146861","url":null,"abstract":"<p><strong>Introduction: </strong>Coeliac disease (CD) often coexists with type 1 diabetes mellitus (T1D). Children with double diagnosis are frequently asymptomatic, which raises the question of whether to introduce a strict gluten-free diet (GFD) or not.</p><p><strong>Aim of the study: </strong>To summarise data on systemic consequences of coeliac disease in children with type 1 diabetes mellitus.</p><p><strong>Material and methods: </strong>The PubMed database was searched for papers to identify meta-analyses, reviews and clinical trials focusing on children.</p><p><strong>Results: </strong>Coeliac disease, like type 1 diabetes may adversely influence glycaemic control, growth, weight gain, lipid profile and bone health as well as increase the risk of vascular complications. A strict gluten-free diet, at least partly, prevents the development of systemic complications of both disorders.</p><p><strong>Conclusions: </strong>Dietary restrictions do not have a negative impact on the quality of life of young diabetic patients hence a gluten-free diet with its multifaceted beneficial effects should be recommended to all children with diabetes and coeliac disease.</p>","PeriodicalId":39165,"journal":{"name":"Pediatric Endocrinology, Diabetes and Metabolism","volume":"30 4","pages":"221-226"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11809550/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143442273","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Hereditary vitamin D resistant rickets (HVDRR) case series: phenotype, genotype, conventional treatment, and adjunctive cinacalcet therapy.","authors":"Noman Ahmad, Sundus A Ansari, Nabil A Aleysae, Emily L G Heaphy, Mrouge M Sobaihi, Balgees A Alghamdi, Ali S Alzahrani","doi":"10.5114/pedm.2024.139367","DOIUrl":"10.5114/pedm.2024.139367","url":null,"abstract":"<p><strong>Introduction: </strong>Hereditary vitamin D resistant rickets (HVDRR) is a rare autosomal recessive disorder marked by end-organ resistance of 1,25-dihydroxyvitamin D secondary to various mutations in the vitamin D receptor gene. The currently accepted treatment modality involves bypassing the affected receptors in the gut with high-dose intravenous calcium. In a few limited case reports, cinacalcet, a calcimimetic, has been used as an adjunctive therapy.</p><p><strong>Material and methods: </strong>Retrospective chart reviews were conducted to collect the clinical and biochemical data of 8 patients with HVDRR from 5 Saudi families. Four patients received only high-dose calcium, while the remaining 4 received adjuvant cinacalcet. Serum chemistry and PTH levels were measured before and during cinacalcet treatment. Gene sequencing was performed to identify the disease-causing mutation.</p><p><strong>Results: </strong>All 8 patients exhibited alopecia and secondary hyperparathyroidism. Other clinical and biochemical features of rickets were present to varying degrees. Genetic analysis revealed 3 distinct mutations: a ligand-binding domain mutation in 3 unrelated patients, a ligand-binding domain mutation in 2 sisters, and a missense DNA-binding domain mutation in 3 brothers. While the overall response to therapy was variable, none of the 4 patients who received adjunctive cinacalcet developed hypocalcaemia, and there was some initial promise in improving serum PTH levels.</p><p><strong>Conclusions: </strong>This series provides new insight into the clinical and biochemical characteristics as well as treatment responses in Saudi children with HVDRR. The findings suggest that cinacalcet is a safe and potentially valuable adjuvant in this understudied population; however, further research is required to verify these results.</p>","PeriodicalId":39165,"journal":{"name":"Pediatric Endocrinology, Diabetes and Metabolism","volume":"30 2","pages":"74-80"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11249798/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141724627","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Primary response in GHD children treatment as a predictor for long-term therapy effectiveness therapy effectiveness.","authors":"Jan M Kapała, Tomasz Maroszczuk, Aleksandra Sitarz, Anna Kącka, Dorota Charemska","doi":"10.5114/pedm.2024.139270","DOIUrl":"10.5114/pedm.2024.139270","url":null,"abstract":"<p><strong>Introduction: </strong>Short stature in growth hormone deficiency (GHD) can be treated with recombinant human growth hormone (rhGH), which is proven to be both safe and effective. However, a considerable number of patients does not achieve satisfying therapy outcomes.</p><p><strong>Aim of the study: </strong>To evaluate the predictive effect of height increase in the first year of rhGH treatment on long-term therapy outcomes.</p><p><strong>Material and methods: </strong>165 short-stature children (mean age 10.72 ±3.33 years; 63% males), diagnosed with GHD, treated with rhGH for at least one year (mean follow-up 4.32 ±1.80 years), divided into 2 groups according to the change in height standard deviation score (SDS) after the first year of rhGH treatment: good responders (GR) and poor responders (PR). Then, in one-year intervals, patient's chronological age, bone age, height, weight, insulin-like growth factor level, and rhGH dose were all assessed.</p><p><strong>Results: </strong>In the GR group, mean height velocity SDS up to five years of observation was 1.19 ±0.41/year and in the PR group 0.59 ±0.38/year. The differences were statistically significant (p < 0.05).</p><p><strong>Conclusions: </strong>The primary response to the rhGH treatment in GHD children seems to be a good predictor for long-term therapy outcomes.</p>","PeriodicalId":39165,"journal":{"name":"Pediatric Endocrinology, Diabetes and Metabolism","volume":"30 2","pages":"61-68"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11249800/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141724631","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Clinical and molecular characterisation of children with monogenic obesity: a case series.","authors":"Arun George, Santhosh Navi, Pamali Nanda, Roshan Daniel, Kiran Anand, Sayan Banerjee, Inusha Panigrahi, Devi Dayal","doi":"10.5114/pedm.2024.140934","DOIUrl":"10.5114/pedm.2024.140934","url":null,"abstract":"<p><strong>Introduction: </strong>To study the clinical profile and molecular diagnosis of children with severe early-onset non-syndromic monogenic obesity.</p><p><strong>Methods: </strong>The clinical and molecular data (performed using whole exome sequencing) of 7 children with early-onset (< 5 years) non-syndromic monogenic obesity were extracted from the Obesity Clinic files and analysed retrospectively.</p><p><strong>Results: </strong>The median (IQR) age at presentation was 18 (10.5-27) months. Of the 7 patients, 5 were boys, 3 had a history of parental consanguinity, and 4 had a family history of severe early-onset obesity. All patients exhibited hyperphagia and showed signs of insulin resistance. Dyslipidaemia and fatty liver were observed in 4. The variants identified in 6 patients included 2 in leptin receptor, and one each in melanocortin 4 receptor, pro-opiomelanocortin, leptin, and neurotrophic tyrosine kinase receptor type 2 genes. Notably, 4 of these variants were novel.</p><p><strong>Conclusions: </strong>This case series provides valuable insights into the spectrum of genetic mutations associated with non-syndromic monogenic obesity in North Indian children. The findings underscore the significance of next-generation sequencing in identifying the aetiology of severe early-onset obesity.</p>","PeriodicalId":39165,"journal":{"name":"Pediatric Endocrinology, Diabetes and Metabolism","volume":"30 2","pages":"104-109"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11249795/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141724697","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Guidelines of the Polish Society of Pediatric Endocrinology and Diabetology and Pediatric Section of Diabetes Poland on insulin therapy using hybrid closed-loop systems in children and adolescents with diabetes in Poland.","authors":"Agnieszka Szadkowska, Agata Chobot, Barbara Głowińska-Olszewska, Przemysława Jarosz-Chobot, Beata Mianowska, Małgorzata Myśliwiec, Agnieszka Szypowska, Agnieszka Zubkiewicz-Kucharska, Mieczysław Walczak","doi":"10.5114/pedm.2024.144041","DOIUrl":"10.5114/pedm.2024.144041","url":null,"abstract":"<p><p>Currently, hybrid closed loop (HCL) systems represent the most advantageous therapeutic option for people with diabetes requiring intensive insulin therapy. They make it possible to achieve optimal metabolic control of the disease in any age group while improving the quality of life of children and adolescents with diabetes and their families. Therefore, we present recommendations for the use of HCL systems in children and adolescents focusing on systems currently available in Poland. These systems should be the first choice in terms of method of insulin therapy in the paediatric population. They can be implemented at any stage of diabetes management. These recommendations are based on scientific evidence and experts' experience. They include principles for the initiation, optimisation, and ongoing management of HCL therapy, as well as the required HCL-related education.</p>","PeriodicalId":39165,"journal":{"name":"Pediatric Endocrinology, Diabetes and Metabolism","volume":"30 3","pages":"132-147"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11538916/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142509820","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Assessment of parents' awareness of the anti-inflammatory diet and its impact on their child's health: survey study.","authors":"Monika Soczewka, Justyna Waśniowska, Katarzyna Krawczyk, Andrzej Kędzia, Bogda Skowrońska, Elżbieta Niechciał","doi":"10.5114/pedm.2024.142589","DOIUrl":"10.5114/pedm.2024.142589","url":null,"abstract":"<p><strong>Introduction: </strong>The latest evidence highlights that an unhealthy diet and poor nutrition status are some of the modifiable behavioural risk factors responsible for the development of non-communicable diseases (NCDs). Anti-inflammatory diets are important in both the treatment and prevention of disease (e.g. hypertension, obesity, Hashimoto's thyroiditis). The concept of these diets has common core foundations and recommendations. The family environment from early childhood plays a particularly important role in shaping healthy eating patterns of children and youths. Thus, parents' nutritional knowledge, attitudes, and dietary practices are essential in preventing NCD development and improving their children's health as their primary guardians. This study aims to assess parents' awareness of an anti-inflammatory diet.</p><p><strong>Material and methods: </strong>A total of 325 parents participated in the study. Data for the study were collected anonymously using the CAWI method. The research tool was an original questionnaire about parents' awareness of anti-inflammatory diets.</p><p><strong>Results: </strong>Of the 325 parents participating in the study, 204 (62.8%) admitted that they did not know which products to use in an anti-inflammatory diet. About half of them (165; 50.8%) had unsatisfactory knowledge of the anti-inflammatory diet, 66 (30.3%) had a good level of knowledge, and only 16 (5.5%) respondents had an excellent level of knowledge.</p><p><strong>Conclusions: </strong>Parental awareness of the use of the anti-inflammatory diet was insufficient in the study group. It seems important to implement appropriate educational activities on the anti-inflammatory diet to expand parents' knowledge of the impact of nutrition on children's development.</p>","PeriodicalId":39165,"journal":{"name":"Pediatric Endocrinology, Diabetes and Metabolism","volume":"30 3","pages":"125-131"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11538915/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142509816","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Adrenal cortical carcinoma: Paediatric aspects - literature review.","authors":"Patrycja Dasiewicz, Elżbieta Moszczyńska, Wiesława Grajkowska","doi":"10.5114/pedm.2024.139271","DOIUrl":"10.5114/pedm.2024.139271","url":null,"abstract":"<p><strong>Introduction: </strong>Adrenocortical carcinoma (ACC) is a rare malignancy in children. Because of this, each patient with suspected ACC requires individualised management, which should be determined at a meeting of a team of multidisciplinary experts in the field.</p><p><strong>Aim of the study: </strong>To summarise data on symptoms, genetic predisposition, and diagnostic procedures for ACC in children.</p><p><strong>Material and methods: </strong>Papers were searched in the PubMed database to identify published randomised clinical trials, reviews, systematic reviews, meta-analyses, and case reports.</p><p><strong>Results: </strong>Most cases of ACC in children occur under the age of 5 years. The most common presenting symptom in 60-80% of paediatric patients is rapidly progressive virilisation. Diagnostics are based on laboratory and imaging evaluation. The mainstay of treatment is surgery, with laparotomy being the preferred method of surgery. Diagnosis is based on histological examination of surgically removed tissue. The Wieneke index is most commonly used in paediatric practice. However, some cases are still classified as \"indeterminate histology\". Predisposing genetic factors are found in most children with ACC, most commonly a mutation of the TP53 gene.</p><p><strong>Conclusions: </strong>Patients should be diagnosed in large clinical centres with experience in this field. The treatment strategy should be individualised. Genetic testing for TP53 gene mutations is indicated in patients with ACC.</p>","PeriodicalId":39165,"journal":{"name":"Pediatric Endocrinology, Diabetes and Metabolism","volume":"30 2","pages":"81-90"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11249794/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141724696","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Less common forms of diabetes in young population.","authors":"Anna Tekielak, Ewa Otto-Buczkowska, Ewa Rusak","doi":"10.5114/pedm.2024.136279","DOIUrl":"10.5114/pedm.2024.136279","url":null,"abstract":"<p><p>Types diabetes other than type 1 are generally considered rare in children and adolescents. The incidence of type 2 diabetes has increased dramatically over the past decade in some ethnic groups. The increased incidence of this type of diabetes mellitus has corresponded tem-porally to unprecedented increases in body weight and obesity prevalence in adolescents in various ethnic populations. Early treatment of insulin resistance is important to prevent the development of diabetes. In therapy, lifestyle modification is essential for weight loss, and if this is not enough, pharmacotherapy is required. Maturity-onset diabetes of the young (MODY), another type of insulin-dependent diabetes, is characterised by early onset and autosomal dominant inheritance. MODY is mainly caused by β-cell defects, resulting in insufficient insulin secretion for a given blood glucose level. Unlike non-insulin-dependent diabetes in youth (NIDDM-Y), there is no significant increase in insulin resistance. The purpose of this article is to characterise and present types of diabetes other than type 1 found in the young population.</p>","PeriodicalId":39165,"journal":{"name":"Pediatric Endocrinology, Diabetes and Metabolism","volume":"30 1","pages":"29-35"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11037089/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141724693","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Transient severe hypotonic hyponatraemia in children - presentation of three cases.","authors":"Joanna A Chrzanowska, Julia Wodniakowska, Aleksander Basiak, Agnieszka Zubkiewicz-Kucharska, Robert Śmigiel","doi":"10.5114/pedm.2024.140933","DOIUrl":"10.5114/pedm.2024.140933","url":null,"abstract":"<p><p>Hyponatraemia, defined as sodium concentration below 135 mmol/l, is one of the most common electrolyte imbalances. Differential diagnosis of hyponatraemia is difficult. We describe 3 cases of children with transient, severe hyponatraemia (< 125 mmol/l). While diagnosing hyponatraemia, it is of major importance to carefully ask in the anamnesis about habits related to the amount of fluid intake and the type of consumed fluids. It should also be noted that a frequent procedure during an infection is to increase fluid ingesting as a prevention of dehydration. One, however, should remember about the possibility of inducing water poisoning in a patient consuming excessive amounts of hypotonic fluids, especially when exposed to non-osmotic antidiuretic hormone stimulus, such as an acute infection or stress, and/or reduced renal excretory capacity. Only the presence of polyuria does not justify a diagnosis of arginine vasopressin deficiency (AVP-D), and especially the implementation of desmopressin treatment before all diagnostic procedures are completed, specifically in the case of hyponatraemia. Desmopressin can be used simultaneously with intravenous 3% saline solution only in the treatment of a very severe hyponatraemia, to avoid overcorrection of natraemia. In patients after profound hyponatraemia, polyuria can be observed after normalisation of fluid intake, but it is temporary.</p>","PeriodicalId":39165,"journal":{"name":"Pediatric Endocrinology, Diabetes and Metabolism","volume":"30 2","pages":"97-103"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11249818/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141724632","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Precocious puberty and other endocrine disorders during mitotane treatment for paediatric adrenocortical carcinoma - case series and literature review.","authors":"Elżbieta Moszczyńska, Marta Baszyńska-Wilk, Aleksandra Tutka, Agnieszka Bogusz-Wójcik, Patrycja Dasiewicz, Olga Gryniewicz-Kwiatkowska, Małgorzata Walewska-Wolf, Maria Stepaniuk, Dorota Majak, Wiesława Grajkowska","doi":"10.5114/pedm.2023.133315","DOIUrl":"10.5114/pedm.2023.133315","url":null,"abstract":"<p><strong>Introduction: </strong>Adrenocortical carcinoma (ACC) is rare and an aggressive tumour. Mitotane is the mainstay adjuvant drug in treating ACC. The study aimed to describe patients diagnosed with precocious puberty (PP) and other endocrinological complications during mitotane therapy.</p><p><strong>Material and methods: </strong>This retrospective study enrolled 4 patients with ACC treated with mitotane therapy complicated by PP. We analysed clinical manifestations, radiological, histopathological findings, and hormonal results.</p><p><strong>Results: </strong>The median age at the diagnosis of ACC was 1.5 years. All patients were treated with surgery and mitotane, accompanied by chemotherapy regimens in 2 cases. The median time from surgery to the initiation of mitotane therapy was 26 days. During mitotane treatment, PP was confirmed based on symptoms, and hormonal and imaging tests. In one patient, incomplete peripheral PP was followed by central PP. The median time from the therapy initiation to the first manifestations of PP was 4 months. Additionally, due to mitotane-induced adrenal insufficiency, patients required a supraphysiological dose of hydrocortisone (HC), and in one patient, mineralocorticoid (MC) replacement with fludrocortisone was necessary. In 2 patients, hypothyroidism was diagnosed. All patients presented neurological symptoms of varying expression, which were more severe in younger children.</p><p><strong>Conclusions: </strong>The side effects of using mitotane should be recognized quickly and adequately treated. In prepubertal children, PP could be a complication of therapy. The need to use supraphysiological doses of HC, sometimes with MC, should be highlighted. Some patients require levothyroxine replacement therapy. The neurotoxicity of mitotane is a significant clinical problem.</p>","PeriodicalId":39165,"journal":{"name":"Pediatric Endocrinology, Diabetes and Metabolism","volume":"30 1","pages":"14-28"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11037260/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141724694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}